Clinical trial
Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in…
NCT00166439 · Academic and Community Cancer Research United, Other · Completed
Key facts
| NCT number | NCT00166439 |
|---|---|
| Title | Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma |
| Official title | A Phase II Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma |
| Lead sponsor | Academic and Community Cancer Research United, Other |
| Collaborators | Mayo Clinic |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) |
| Enrollment | 50 |
| Start date | Mar 1, 2005 |
| Primary completion | Sep 1, 2015 |
| Completion | Sep 1, 2015 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 14, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: